Lamotrigine and the risk of malformations in pregnancy.
作者信息
Hauser W Allen, Tomson Torbjörn
出版信息
Neurology. 2006 Jan 10;66(1):153-4; author reply 153-4. doi: 10.1212/01.wnl.0000203710.88804.29.
Abstract
摘要
相似文献
1
Lamotrigine and the risk of malformations in pregnancy.
Neurology. 2006 Jan 10;66(1):153-4; author reply 153-4. doi: 10.1212/01.wnl.0000203710.88804.29.
2
Lamotrigine and the risk of malformations in pregnancy.
Neurology. 2005 Mar 22;64(6):955-60. doi: 10.1212/01.WNL.0000154515.94346.89.
3
Commentary: Triptan use during pregnancy: a safe choice?
Headache. 2010 Apr;50(4):576-8. doi: 10.1111/j.1526-4610.2010.01650.x.
4
Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
Arch Neurol. 2011 Oct;68(10):1275-81. doi: 10.1001/archneurol.2011.133. Epub 2011 Jun 13.
5
What can we say to women of reproductive age with epilepsy?
Neurology. 2005 Mar 22;64(6):938-9. doi: 10.1212/01.WNL.0000154464.36610.91.
6
Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Lancet Neurol. 2011 Jul;10(7):609-17. doi: 10.1016/S1474-4422(11)70107-7. Epub 2011 Jun 5.
7
Increased rate of major malformations in offspring exposed to valproate during pregnancy.
Neurology. 2005 Mar 22;64(6):961-5. doi: 10.1212/01.WNL.0000154516.43630.C5.
8
Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy.
Neurology. 2009 Mar 24;72(12):1108; author reply 1108-9. doi: 10.1212/01.wnl.0000346463.44116.56.
9
Short- and long-term complications of in utero exposure to lamotrigine.
Br J Clin Pharmacol. 2018 Jan;84(1):189-194. doi: 10.1111/bcp.13437. Epub 2017 Oct 22.
10
Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment.
Am J Obstet Gynecol. 2000 Jan;182(1 Pt 1):159-63. doi: 10.1016/s0002-9378(00)70506-0.
Zotero 插件